Mice Antibody Response to Avian Influenza Vaccine
Author Information
Author(s): Horthongkham Navin, Srihtrakul Tananun, Athipanyasilp Niracha, Siritantikorn Sontana, Kantakamalakul Wannee, Poovorawan Yong, Sutthent Ruengpung
Primary Institution: Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Hypothesis
Can recombinant proteins from avian influenza H5N1 induce a specific antibody response in mice?
Conclusion
Recombinant proteins produced in mammalian cells induce a significantly higher antibody response compared to those produced in E. coli.
Supporting Evidence
- The HA and NS recombinant proteins produced in COS-7 cells induced significantly higher antibody titers than those produced in E. coli.
- Immunization with 250 μg of recombinant proteins showed the best antibody response.
- The study demonstrated that the recombinant proteins could neutralize heterologous avian influenza virus.
Takeaway
Scientists made a vaccine from bird flu proteins and tested it on mice to see if it could help them fight the virus.
Methodology
Mice were immunized with recombinant proteins at various doses, and antibody responses were measured using ELISA and neutralization assays.
Limitations
The study primarily focused on in vitro responses and did not include long-term efficacy or safety assessments in live animals.
Participant Demographics
Female Balb/c mice, 6 to 8 weeks old.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website